News & Updates
Showing Endocrinology articles
Showing
Show Multimedia Only

T2D risk elevated in thyroid cancer patients after thyroidectomy
05 Mar 2022
Development of type 2 diabetes (T2D) is more likely to occur among patients with thyroid cancer who underwent thyroidectomy than matched controls, a Korea study has shown. In addition, a U-shaped dose-dependent relationship exists between the levothyroxine dosage and T2D risk.
05 Mar 2022

T2D: Risk of CV and all-cause mortality lower with SGLT2 vs DPP-4 inhibitors
05 Mar 2022
byNatalia Reoutova
A real-world propensity score-matched study in Hong Kong finds that, compared with use of dipeptidyl peptidase-4 (DPP-4) inhibitors, use of sodium-glucose cotransporter 2 (SGLT2) inhibitors in type 2 diabetes (T2D) patients is associated with lower risk of incident atrial fibrillation (AF), stroke/transient ischaemic attack (TIA), and cardiovascular (CV) and all-cause mortality.
05 Mar 2022






